Apogee Therapeutics (APGE) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.88
-0.78
-0.68
-0.59

Details

Expected EPS
-0.879014
Actual EPS
-0.86
Surprise EPS
0.02
Surprise Percent
+2.16%

Description

Apogee Therapeutics (APGE) has reported earnings of -0.86 per share for Q4 2024.

0 Comments

Share your thoughts